![Richard Batycky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Batycky
Director/Board Member at
PULMATRIX, INC.
Net worth: 35 $ as of 2026-05-30
Profile
Richard P.
Batycky was the founder of Civitas Therapeutics, Inc., founded in 2009, where the title held was Chief Scientific Officer from 2009 to 2014.
Current jobs include President, Chief Executive Officer & Director at Nocion Therapeutics, Inc. since 2018; Director at Pulmatrix Operating Co., Inc. since 2007; and Independent Director at Pulmatrix, Inc. since 2019.
Former jobs include Vice President at Alkermes, Inc. from 1999 to 2013; Chief Technology Officer at Acorda Therapeutics, Inc.; and Principal at Advanced Inhalation Research, Inc. Education includes undergraduate degree from the University of Calgary and graduate and doctorate degrees from the Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-22 | 25 ( 0% ) | 35 $ | 2026-05-30 |
Richard Batycky active positions
| Companies | Position | Start |
|---|---|---|
| PULMATRIX, INC. | Director/Board Member | 2019-10-31 |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Director/Board Member | - |
Nocion Therapeutics, Inc.
 Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Chief Executive Officer | 2018-07-31 |
Former positions of Richard Batycky
| Companies | Position | End |
|---|---|---|
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Founder | 2014-10-31 |
| ACORDA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Advanced Inhalation Research, Inc.
 Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Develops dry-powder drug delivery system for respiratory patients | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Training of Richard Batycky
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
Advanced Inhalation Research, Inc.
Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Develops dry-powder drug delivery system for respiratory patients | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Health Technology |
- Stock Market
- Insiders
- Richard Batycky
